Plus Therapeutics, Inc.

Plus Therapeutics is a U.S. clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with difficult-to-treat cancer. Their mission is to improve the efficacy, precision, and convenience of radiotherapeutics, aiming to make their therapies a global standard of care for cancer. Plus Therapeutics utilizes a hybrid virtual drug development model, which allows them to be capital efficient, enhance operational efficiencies, decrease costs, and accelerate product development.

The company's radiotherapeutic platform leverages the versatile radionuclide Rhenium, which emits beta energy for precisely targeting tumors and gamma energy for live imaging throughout treatment. Their two lead product candidates, rhenium (186Re) obisbemeda and Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), are being evaluated in clinical trials for a variety of cancers, including brain tumors, liver cancer, and leptomeningeal metastases. Plus Therapeutics is headquartered in Austin, Texas, with additional laboratories and state-of-the-art clean rooms in San Antonio, Texas.

Plus Therapeutics offers a hybrid virtual drug development model that allows employees to work remotely. This allows for flexibility in work location and schedule, and is intended to be capital efficient, enhance operational efficiencies, decrease costs, and accelerate product development. The company is headquartered in Austin, Texas, with additional laboratories and state-of-the-art clean rooms in San Antonio, Texas.

Plus Therapeutics fosters a workplace culture that prioritizes both personal and professional development, offering employees the opportunity to grow within the company. While the company maintains a fast-paced and innovation-focused environment, they strive to create a culture of respect and value for employees, ensuring they feel supported in their journey with the company. They are an equal opportunity employer, committed to diversity and fairness in the workplace.

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing innovative, targeted radiotherapeutics for adults and children battling difficult-to-treat cancers. They aim to improve the efficacy, precision, and convenience of radiotherapeutics by developing a versatile platform leveraging novel formulations with beta- and gamma-energy-emitting Rhenium radionuclides, nanoliposomes, and biodegradable microspheres.

Plus Therapeutics promotes a culture that prioritizes both personal and professional development, valuing accountability, agility, communication, innovation, integrity, patient-centricity, performance, respect, teamwork, and experience. The company strives to create a fast-paced, innovation-focused environment where employees feel respected and valued, fostering a sense of community and collaboration.

Plus Therapeutics is committed to fostering a workplace culture built on both personal and professional development, ensuring employees feel respected and valued. As an equal opportunity employer, the company is dedicated to diversity and fairness in the workplace. They prioritize accountability, agility, communication, innovation, integrity, patient-centricity, performance, respect, teamwork and experience. Their focus is on creating a diverse and inclusive workplace that values differing perspectives and encourages collaboration.